Yes, Hyrimoz is FDA-approved. It was approved by the U.S. Food and Drug Administration (FDA) in October 2018. Hyrimoz is a biosimilar to Humira, meaning it is highly similar to the original drug. This means it’s been rigorously tested and shown to be safe and effective for the same conditions as Humira.
